V C Knick
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Elizabeth A. Austin (2 shared papers)Brian E. Huber (2 shared papers)David P. Baccanari (2 shared papers)C A Richards (1 shared paper)Steven S. Good (1 shared paper)Doris M. Murray (1 shared paper)T Spector (1 shared paper)Stephen T. Davis (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)Xenobiotica (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
V C Knick
12 papers receiving 822 citations
Peers
Comparison fields: 5 of 75
- Biotechnology 131
- Oncology 321
- Genetics 256
- Molecular Biology 394
- Organic Chemistry 157
Countries citing papers authored by V C Knick
This map shows the geographic impact of V C Knick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V C Knick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V C Knick more than expected).
Fields of papers citing papers by V C Knick
This network shows the impact of papers produced by V C Knick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V C Knick. The network helps show where V C Knick may publish in the future.
Co-authors
The 25 scholars most cited alongside V C Knick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. | 1993 | 198 |
| 2 | Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. | 1995 | 156 |
| 3 | 1993 | 117 | |
| 4 | Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. | 1993 | 102 |
| 5 | 1996 | 100 | |
| 6 | 1990 | 73 | |
| 7 | 1995 | 63 | |
| 8 | 1995 | 26 | |
| 9 | 2003 | 18 | |
| 10 | Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivo. | 1990 | 13 |
| 11 | 1992 | 9 | |
| 12 | 1990 | 1 |
About V C Knick
V C Knick is a scholar working on Oncology, Biotechnology, Organic Chemistry, Epidemiology and Molecular Biology, having authored 12 papers that have together received 876 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Quinazolinone synthesis and applications (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Virus-based gene therapy research (2 papers), Synthesis and Biological Evaluation (2 papers), Cancer therapeutics and mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Biotechnology (131 citations), Oncology (321 citations), Genetics (256 citations), Molecular Biology (394 citations) and Organic Chemistry (157 citations). V C Knick has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Elizabeth A. Austin, Brian E. Huber, David P. Baccanari, C A Richards, Steven S. Good, Doris M. Murray, T Spector, Stephen T. Davis, Derek J. Eberwein and Cathie G. Miller. Their work appears in journals such as Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, Xenobiotica, JNCI Journal of the National Cancer Institute and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.